Business
-
Jul 27 2022Sun Pharma and Cosmo announce territory expansion of license and supply agreements for WINLEVI
Sun Pharmaceutical Industries and Cassiopea, a subsidiary of Cosmo Pharmaceuticals…
Read more -
Jul 27 2022Australia provisionally approves Moderna’s COVID shot for children aged below five years
So far, the shot was provisionally approved in the country…
Read more -
Jul 27 2022EU signs COVID-19 drug procurement deal with Gilead
The European Commission has signed a joint procurement contract for…
Read more -
Jul 27 2022US CDC recommends Novavax’s COVID-19 vaccine for adults
The US government has secured 3.2 million Novavax vaccine doses,…
Read more -
Jul 13 2022India to emerge as largest destination for medical tourism
At the recently concluded Global Investment in Ayush Summit, India’s…
Read more -
Jul 11 2022Indian Immunologicals Ltd (IIL) to expand New Zealand Operations – subsidiary Pristine Biologicals NZ inaugurates New Sterile Filtered Serum manufacturing facility in Dargaville, New Zealand
Pristine Biologicals NZ Ltd, a subsidiary of Indian Immunologicals Ltd…
Read more -
Jul 10 2022Prof. Dr. Kannan Vishwanatth floors the V International Economic Forum at Riga, Latvia on The COVID Crisis and Opportunities for Human Well-Being.
Dr. Kannan Vishwanatth of Rupus Global Limited addressed in Plenary…
Read more -
Jul 09 2022India’s pharma logistics, warehousing costs 15% higher than other countries.
The GS1 India study showed more than 50 per cent…
Read more -
Jul 06 2022Prof. Dr. Kannan Vishwanatth of Rupus Global Limited joins as the Advisory Board Member of the The School Advisory Council, the HKUST Business School.
Noted Academic Researcher & Rupus Global Limited Managing Director Prof.…
Read more -
Jul 04 2022Skye Bioscience gets Australian HREC nod to begin first-in-human phase 1 study of SBI-100 ophthalmic emulsion
Skye Bioscience, Inc., a pharmaceutical company developing a proprietary, synthetic…
Read more
